236 related articles for article (PubMed ID: 17980013)
1. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism.
Moosgaard B; Christensen SE; Vestergaard P; Heickendorff L; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2008 May; 68(5):707-15. PubMed ID: 17980013
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
4. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
5. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
[TBL] [Abstract][Full Text] [Related]
6. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
7. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
Walker MD; Saeed I; Lee JA; Zhang C; Hans D; Lang T; Silverberg SJ
Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL
J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
[TBL] [Abstract][Full Text] [Related]
9. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
Lee JH; Kim JH; Hong AR; Kim SW; Shin CS
Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
[TBL] [Abstract][Full Text] [Related]
10. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
[TBL] [Abstract][Full Text] [Related]
11. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.
Viccica G; Cetani F; Vignali E; Miccoli M; Marcocci C
Endocrine; 2017 Jan; 55(1):256-265. PubMed ID: 27033542
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperparathyroidism and the skeleton.
Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
14. BMD improvements after operation for primary hyperparathyroidism.
Rolighed L; Vestergaard P; Heickendorff L; Sikjaer T; Rejnmark L; Mosekilde L; Christiansen P
Langenbecks Arch Surg; 2013 Jan; 398(1):113-20. PubMed ID: 23132462
[TBL] [Abstract][Full Text] [Related]
15. 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.
Christensen MH; Apalset EM; Nordbø Y; Varhaug JE; Mellgren G; Lien EA
PLoS One; 2013; 8(2):e56019. PubMed ID: 23418495
[TBL] [Abstract][Full Text] [Related]
16. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study.
Wamberg L; Pedersen SB; Richelsen B; Rejnmark L
Calcif Tissue Int; 2013 Jul; 93(1):69-77. PubMed ID: 23591713
[TBL] [Abstract][Full Text] [Related]
17. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism.
Shetty S; Cherian KE; Shetty S; Kapoor N; Jebasingh FK; Cherian A; Hephzibah J; Chandramohan A; John RA; Asha HS; Paul MJ; Manipadam MT; Abraham DT; Thomas N; Paul TV
Endocr Pract; 2020 Dec; 26(12):1442-1450. PubMed ID: 33471736
[TBL] [Abstract][Full Text] [Related]
18. Prediction of bone mass changes after successful parathyroidectomy using biochemical markers of bone metabolism in primary hyperparathyroidism: is it clinically useful?
Ohe MN; Bonanséa TCP; Santos RO; Neves MCD; Santos LM; Rosano M; Kunii IS; Castro ML; Vieira JGH
Arch Endocrinol Metab; 2019 Jul; 63(4):394-401. PubMed ID: 31365627
[TBL] [Abstract][Full Text] [Related]
19. Associations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D With Bone Mineral Density, Bone Mineral Density Change, and Incident Nonvertebral Fracture.
Swanson CM; Srikanth P; Lee CG; Cummings SR; Jans I; Cauley JA; Bouillon R; Vanderschueren D; Orwoll ES; Nielson CM;
J Bone Miner Res; 2015 Aug; 30(8):1403-13. PubMed ID: 25707402
[TBL] [Abstract][Full Text] [Related]
20. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
